Rare diseases
Investigational molecules
Locations
Back to Spain155 clinical trials in Lugo, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
SpainStudy to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery
SpainLong-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel
SpainStudy of Once‑Weekly Eloralintide (LY3841136 Sodium) in Adults with Obesity or Overweight, Type 2 Diabetes, and High Cardiovascular Risk
SpainPhase 3 Study of Enfortumab Vedotin plus Pembrolizumab in Adults with Muscle‑Invasive Bladder Cancer Ineligible for Cystectomy
SpainStudy of elranatamab, mezigdomide and dexamethasone in patients with relapsed/refractory multiple myeloma
SpainSafety and Efficacy of Extended‑Release Tacrolimus (VI‑0106) in Adults with Pulmonary Arterial Hypertension and Functional Limitations
SpainELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition
SpainA study of pembrolizumab, belzutifan, and lenvatinib before main treatment in patients with localized kidney cancer
SpainA study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease
SpainA study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on metastatic prostate cancer, breast cancer, and non-small cell lung cancer treatments. Studies evaluate innovative therapies including immunotherapy combinations and targeted treatments.
Multiple trials exploring both neoadjuvant and adjuvant treatment approaches to improve patient outcomes.
Clinical research examining treatments for advanced colon cancer, pancreatic adenocarcinoma, and urothelial cancer. Studies evaluate neoadjuvant chemotherapy effectiveness and novel drug combinations.
Focus on improving survival rates through optimized treatment sequences and combinations.
Innovative research in IgA nephropathy and related conditions. Studies evaluate new therapeutic agents and their combinations with existing treatments to improve patient outcomes.
Emphasis on developing targeted therapies for chronic kidney conditions and immune-mediated disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
